ABVC BioPharma Agrees to Sell $4.11 Million in Convertible Notes
ABVC BioPharma agreed to sell $4.11 million in principal amount of senior convertible notes for $3.39 million. Proceeds are intended for working capital, subsidiary funding and a payment to Lind. The company also reached a settlement with Lind requiring a $625,000 payment.
ABVC BioPharma agreed to sell $4.11 million in principal amount of senior convertible notes for a purchase price of $3.39 million, with proceeds intended for working capital, subsidiary funding and a payment to Lind. Separately, the company reached a settlement with Lind requiring a $625,000 paymen…